Caribou Biosciences, Inc. (CRBU)
NASDAQ · Healthcare
Caribou Biosciences, Inc. EBITDA 2019–2025
Caribou Biosciences, Inc. annual/quarterly ebitda history and growth rate from 2019 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Caribou Biosciences, Inc. ebitda for the quarter ending March 31, 2026 was -25.6 M, a 38.61% decrease year-over-year.
- Caribou Biosciences, Inc. ebitda for the twelve months ending March 31, 2026 was -143.2 M.
- Caribou Biosciences, Inc. annual ebitda for 2025 was -144.7 M, a 11.06% decrease from 2024.
- Caribou Biosciences, Inc. annual ebitda for 2024 was -162.7 M, a 44.57% increase from 2023.
- Caribou Biosciences, Inc. annual ebitda for 2023 was -112.5 M, a 7.40% increase from 2022.
- Caribou Biosciences, Inc. annual ebitda for 2022 was -104.8 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Caribou Biosciences, Inc. EBITDA — FAQ
Caribou Biosciences, Inc. (CRBU) ebitda over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRBU's ebitda history?
The chart and table above show Caribou Biosciences, Inc.'s ebitda by year and by quarter, including the growth rate.